Approval · Notice of Compliance 3525 · 2003
EQUIPOISE INJECTABLE: Notice of Compliance 3525
Issued February 17, 2003
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 3525
- Date
- February 17, 2003
- Company
- Wyeth Animal Health, Division Of Wyeth CanadaKirkland, Quebec, Canada
- Product type
- Veterinary
- Submission
- New Drug Submission (NDS)
- Submission class
- Other
- Therapeutic class
- Anabolic steroid
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| EQUIPOISE INJECTABLE | 02223619 | Cancelled Post Market |
Medicinal ingredients
- BOLDENONE UNDECYLENATE 50 MG per ML